The FDA suspended two clinical trials and a portion of a third testing Merck’s Keytruda as a treatment for blood cancer, after more patients receiving the drug died than those receiving other treatments.
from WSJ.com: US Business http://ift.tt/2uM2hTf
via IFTTT
No comments:
Post a Comment